By Catherine Eckford2026-01-09T12:41:18
His appointment comes as the pharma company AstraZeneca seeks to hit $80 billion revenue target by 2030.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-21T08:24:00Z
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2025-10-08T07:00:00
Sponsored by Entegris
2025-09-17T08:00:00
Sponsored by Mastercontrol
2026-05-13T14:00:00 2026-05-13T15:00:00
Sponsored by Thermo Fisher Scientific
2025-06-26T08:43:00
Sponsored by Uniphar, By Tom Smith (Uniphar)
Site powered by Webvision Cloud